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ABSTRACT Treatment ofmet-myoglobin (FeIII) withH2O2 gives rise to ferrylmyoglobin, which is closely related to compound II in
peroxidases. Experimental studies have given conﬂicting results for this species. In particular, crystallographic and extended x-ray
absorption ﬁne-structure data have shown either a short (;170 pm) or a longer (;190pm) Fe–Obond, indicating either a double or
a single bond. We here present a combined experimental and theoretical investigation of this species. In particular, we use
quantum reﬁnement to re-reﬁne a crystal structure with a long bond, using 12 possible states of the active site. The states differ in
the formal oxidation state of the iron ion and in the protonation of the oxygen ligand (O2, OH, or H2O) and the distal histidine
residue (with a proton on Nd1, Ne2, or on both atoms). Quantum reﬁnement is essentially standard crystallographic reﬁnement,
where themolecular-mechanics potential, normally used to supplement the experimental data, is replaced by a quantum chemical
calculation. Thereby, weobtain an accurate description of the active site in all the different protonation and oxidation states, andwe
can determine which of the 12 structures ﬁt the experimental data best by comparing the crystallographic R-factors, electron-
density maps, strain energies, and deviation from the ideal structure. The results indicate that FeIII OH and FeIV OH ﬁt the
experimental data almost equally well. These two states are appreciably better than the standardmodel of compound II, FeIV O2.
Combinedwith theavailable spectroscopic data, this indicates that compound II inmyoglobin is protonatedand isbest describedas
FeIV OH. It accepts a hydrogen bond from the distal His, which may be protonated at low pH.
INTRODUCTION
Myoglobin is the major heme-containing protein of cardiac
and skeletal muscle and serves as an oxygen buffer in
respiring tissues. The oxygen afﬁnity of myoglobin lies
between that of hemoglobin, which releases oxygen in
passing through respiring tissues, and cytochrome c oxidase,
which uses molecular oxygen in oxidative respiration. It is
the high myoglobin content that gives continually respiring
tissues their red color.
Myoglobin has been studied intensively for decades
(Philips, 2001) and it was the ﬁrst protein for which the
three-dimensional structure was solved (Kendrew et al.,
1960). The structure showed a globular protein, built up
mainly from a-helices. The active site of myoglobin is
situated in a hydrophobic pocket near the center of the
molecule and consists of a prosthetic heme group (iron
protoporphyrin IX) with a FeII ion in the center of a porphyrin
ring, coordinated by the four nitrogen atoms of the pyrrole
rings. The ion is also bound to the Ne2 atom of the conserved
proximal histidine (His) residue. The sixth coordination site,
completing the octahedral coordination around the iron ion,
is empty or occupied by O2. A nearby His residue (the distal
His) forms a hydrogen bond to the bound O2 molecule,
thereby stabilizing the binding and favoring O2 compared to
other competing diatomic gases, e.g., CO and NO (Spiro and
Kozlowski, 2001). Mutation of the proximal His ligand or
surrounding hydrophobic side chains in general leads to
dissociation of the heme group (Hargrove et al., 1996).
Heme groups are also present in many other proteins.
They show an impressively varied chemistry, with functions
ranging from electron transfer (cytochromes) to binding and
transport of small molecules and catalysis of a great wealth
of reactions (e.g., peroxidases, oxidases, and catalases; see
da Silvia and Williams, 1994; Kaim and Schwederski, 1994;
Smith and Veitch, 1998; Matsunaga and Shir, 2004). All
these proteins bind heme, but the surrounding protein and the
axial ligand vary extensively between different groups of
proteins and are considered to tune the properties of the heme
group (Poulos, 1996).
Much effort has been put into investigations of the
reaction cycles of these heme proteins. The reaction cycle of
peroxidases (Gajhede, 2001; and see Fig. 1, this article) starts
with the resting FeIII state, which is either six-coordinate
with a water molecule (1) or ﬁve-coordinate with an empty
coordination site (2). This state binds H2O2 (3), which is then
deprotonated to a hydroperoxide intermediate (4). When this
intermediate is re-protonated on the distal oxygen atom, the
O–O bond breaks automatically in a heterolytic manner,
resulting in water and compound I (5; formally FeV O2, but
one of the reducing equivalents is located in the porphyrin
ring or on a nearby protein residue). Compound I is ex-
tremely reactive and can abstract an electron from almost
any substrate (the reduction potential is close to 1 V;
Gajhede, 2001). This results in a substrate radical and
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compound II (FeIV O2; 6). Compound II is also reactive
with a similar reduction potential and can abstract an electron
from another substrate molecule, thereby returning to the
resting state after the uptake of two protons.
The normal function of myoglobin is to bind and store O2.
However, it has been shown that it may also support a
peroxidase-like activity, i.e., a H2O2-dependent oxidation of
many substrates (Giulivi and Cadenas, 1994). During the
reversible O2 binding, oxymyoglobin auto-oxidizes at a
relatively slow rate (Tajima and Shikama, 1987) to yield
met-myoglobin (i.e., FeIII) and a superoxide radical (O2 ).
The latter disproportionates to H2O2 and O2. H2O2 is a
reactive species and can cause potential damage. The per-
oxidase activity of myoglobin may take care of this prob-
lem (Giulivi and Cadenas, 1994). The reaction product of
H2O2 with met-myoglobin is considered to be compound I
(Keilin and Hartree, 1950). This species is labile and rapidly
takes up an electron by a poorly known mechanism to form
compound II (ferryl myoglobin), which is quite stable
(Giulivi and Cadenas, 1994). It has also been suggested that
the O–O bond may break homolytically, giving rise to
compound II and a hydroxyl radical (neutral OH_). Native
myoglobins possess a lower peroxidase activity than
peroxidases, which has been attributed to the absence of
a distal arginine residue and the failure of the distal histidine
to function as an acid-base catalyst (Matsui et al., 1999). By
mutations that place the histidine in a similar distance to
the heme as in the active site of peroxidases, compound I
of myoglobin has been observed, probably owing to an in-
creased rate of heterolysis (Ozaki et al., 1997; Matsui et al.,
1999). However, compound I has also been observed for native
myoglobin through stopped-ﬂow rapid-scan spectrophoto-
metry (Egawa et al., 2000).
Earlier crystallographic and extended x-ray absorption
ﬁne-structure (EXAFS) investigations have indicated that the
Fe–O bond length in compound II in myoglobin, horseradish
peroxidase (HRP), and catalase is 164–171 pm, i.e., close to
what has been observed for compound I (Chance et al.,
1986a; Penner-Hahn et al., 1986; Gouet et al., 1996), thereby
indicating that it is a FeIV O2 species. However, in three
recent crystal structures of compound II in myoglobin, HRP,
and catalase, appreciably longer Fe–O bonds were observed,
184–192 pm (Hersleth et al., 2002; Berglund et al., 2002;
Murshudov et al., 2002). Such a long Fe–O bond was also
observed in a recent crystal structure of compound I in
cytochrome c peroxidase (187 pm), which is electronically
equivalent to compound II of HRP, because the other
oxidizing equivalent is on a tryptophane residue (Bonagura
et al., 2003). A similar bond length (193 pm) has also been
reported in an EXAFS study of compound II in HRP
(Chance et al., 1984). This was interpreted as a protonation
of O2 to OH or even as FeIII OH_. However, this
interpretation was recently questioned in another EXAFS
study of chloroperoxidase and HRP, which gave a long Fe–O
bond only for the former enzyme (Green et al., 2004).
Considering the importance of compound II in the catalytic
cycle of many different types of enzymes, it is highly in-
teresting to settle the actual character of compound II. In this
article we therefore use our recently developed quantum-
reﬁnement method (Ryde et al., 2002) to re-reﬁne the crystal
structure of compound II in myoglobin using various oxi-
dation and protonation states of the active site, to see which
ﬁt the experimental data best.
METHODS
Quantum reﬁnement
Quantum reﬁnement (Ryde et al., 2002; Ryde and Nilsson, 2003b) is
essentially standard crystallographic reﬁnement supplemented by quantum
chemical calculations for a small part of the protein. Crystallographic re-
ﬁnement programs change the protein model (coordinates, occupancies,
B-factors, etc.) to improve the ﬁt of the observed and calculated structure-
factor amplitudes (usually estimated as the residual disagreement, the
R-factor). Owing to the limited resolution normally obtained for biomole-
cules, the experimental data are supplemented by some chemical information,
usually in the form of amolecular-mechanics (MM) force ﬁeld (Kleywegt and
Jones, 1998). Then, the reﬁnement takes the form of a minimization or
simulated annealing calculation by molecular dynamics using an energy
function of the form
Ecryst ¼ wAEXray1EMM; (1)
where EXray is a penalty function that describes how well the model agrees
with the experimental data (we have used a maximum-likelihood reﬁnement
target using amplitudes, MLF; see Pannu and Read, 1996; Adams et al.,
1997). EMM is an MM energy function with bond, angle, dihedral, and
FIGURE 1 The proposed reaction cycle for peroxidases (Gajhede, 2001).
Compounds I and II are complexes 5 and 6.
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nonbonded terms, and wA is a weight factor, which is necessary because
EMM is in energy units whereas EXray is in arbitrary units. It determines the
relative importance of the crystallographic raw data and the MM force ﬁeld
for the ﬁnal structure.
Quantum chemistry can be introduced in this function by replacing the
MM potential for a small (but interesting) part of the protein (system 1) by
a quantum mechanics (QM) calculation, yielding a QM energy for system 1,
EQM1. To avoid double counting we must then subtract the MM energy of
system 1, EMM1,
Etot ¼ wAEXray1EMM1wQMEQM1  EMM1: (2)
Thereby, we introduce an accurate energy function for the system of interest.
Such an energy function is implemented in the software ComQum-X (Ryde
et al., 2002),which is a combination of the software TURBOMOLE (Ahlrichs
et al., 2000) and the crystallography and NMR system (CNS) (Bru¨nger et al.,
2000). The factorwQM in Eq. 2 is anotherweight, which is needed because the
CNS MM force ﬁeld is based on a statistical analysis of crystal structures
(Engh and Huber, 1991). Therefore, the force constants are not energy-
derived, as is theQMterm, but they are in arbitrary statistical units. Experience
has shown that the CNS force constants are typically three times larger than
energy-based force constants (Engh and Huber, 1991), and wQM ¼ 3 has
therefore been used throughout this work (Ryde et al., 2002).
Special attention is needed if there is a covalent bond between the QM
system and the surrounding proteins. This is a well-known problem in the
popular combined QM and MM methods (QM/MM; Monard and Merz,
1999; Mulholland, 2001; Ryde, 2003) (ComQum-X can also be seen as a
QM/MM method with restraints to crystallographic raw data), and a simple
and robust solution (Nicoll et al., 2001) is to truncate the QM system with
hydrogen atoms, the positions of which are linearly related to the corre-
sponding carbon atom in the protein (Ryde et al., 2002). Of course, EMM1
is also calculated with these hydrogen atoms, so that artifacts intro-
duced by the hydrogen truncation may cancel out. Following crystallo-
graphic custom, protons and electrostatic interactions are ignored in the
reﬁnement, except of course in the quantum chemical calculations.
ComQum-X has been tested by re-reﬁning the structure of
N-methylmesoporphyrin bound to ferrochelatase (Ryde et al., 2002). The
results showed that we may improve the structure locally in terms of the Rfree
factor (the Rfree factor is an R-factor calculated for a set of randomly chosen
intensities, typically ;5%, which are set aside from the beginning and not
used during the reﬁnement; Bru¨nger, 1993).Moreover, we have shown (Ryde
andNilsson, 2003a) that reﬁnementwithComQum-Xof amedium-resolution
(170 pm) crystal structure of cytochrome c553 brings the geometry of the
heme group and its ligands closer to that observed in an atomic-resolution
structure (97 pm) of the same protein (Benini et al., 2000). For example, the
errors in the Fe-ligand distances are reduced from 3–9, 12, and 32 pm to 1, 0,
and 2 pm (for the porphyrin, histidine, and methionine ligands, respectively).
We have also shown that ComQum-X can be used to deduce the protonation
state of metal-bound solvent molecules in protein structures (Ryde and
Nilsson, 2003b; Nilsson and Ryde, 2004). We used the catalytic zinc ion in
alcohol dehydrogenase as a test case, because the pKa of the zinc-boundwater
molecule is known fromkineticmeasurements, andwewere able to reproduce
the correct protonation state of both an alkoxide ion and a water molecule.
Computational details
The quantum-reﬁnement calculations and vacuum geometry optimizations
were performed with the density functional Becke-Perdew86 method
(Becke, 1988; Perdew, 1986). They were sped up by expanding the
Coulomb interactions in an auxiliary basis set, the resolution-of-identity
approximation (Eichkorn et al., 1995, 1997). These calculations employed
the DZpdf basis set for iron (Scha¨fer et al., 1992; Sigfridsson et al., 2001)
and the 6-31G* basis set for all other atoms, except the O-ligand, for which
a set of diffuse functions (6-311G*) was also included (Hehre et al., 1986).
Most of the calculations were run on the model Fe(Por)(Im)(H2O/OH
/
O2) (Im), where Por is porphine, i.e., the porphyrin ring without side chains
(our previous calculations have shown that the porphyrin side chains have
a minor effect on the geometry of the heme group; Sigfridsson and Ryde,
2003) and Im is imidazole, the standard model of His residues. Thus, the
model includes both the proximal His ligand and the distal His residue.
However, some vacuum calculations were run on a smaller complex without
the model of the distal His residue.
All quantum-reﬁnement calculations are based on the crystal structure of
compound II in myoglobin at 135-pm resolution (collected at 100 K, pH 5.2;
Hersleth et al., 2002). Coordinates, occupancies, B-factors, and structure
factors of the structure were obtained from the Brookhaven Protein Data
Bank ﬁles 1GJN. From these ﬁles we also obtained the space group, unit-cell
parameters, resolution limits, R-factors, and the test set used for the eval-
uation of the Rfree factor.
The full protein was used in all calculations, including all crystal water
molecules in the Protein Data Bank ﬁle. The full geometry of the proteins was
optimized until the change in Etot was below 10
6 Hartree (2.6 J/mol) and the
norm of the Cartesian gradients was below 103 a.u. In each cycle of the
geometry optimization, the surrounding protein was allowed to relax by one
cycle of crystallographic minimization and one cycle of individual B-factor
reﬁnement.However, the newcoordinates andB-factorswere accepted only if
the Rfree factor was reduced. For the protein, we used the standard CNS force
ﬁeld (protein_rep.param, water_rep.param, and ion.param) and for the heme
group, the parameter ﬁle from the original reﬁnement (these parameters are of
little importance, because the heme group is treated by quantum chemistry in
the reﬁnement). For the other program parameters, we used data from the
Protein Data Bank ﬁles or the default choices.
The wA factor in Eq. 2, poses a special problem, because it is the only
undetermined parameter in ComQum-X. In standard crystallographic
reﬁnements, it is determined so that the MM and crystallographic forces
have a similar magnitude (Bru¨nger and Rice, 1997). However, there is no
warranty that this is the optimum choice, especially not if a part of the
protein is supplemented by a QM energy function. Therefore, we have
determined the optimum choice of wA for each system by optimizing the
Rfree factor. This was done by reﬁning each structure at (at least) ﬁve
different values of wA, 0.006, 0.06, 0.25 (the default choice of CNS), 1, and
6. The Rfree factor was always lowest for wA ¼ 0.25 or 1 and increased
monotonously for higher and lower values of wA.
Relative energies of the various protein complexes were estimated by
solving the Poisson-Boltzmann equation numerically using MEAD 2.2
software (Bashford, 1997; Tishmack et al., 1997). Charges for the quantum
system were ﬁtted to the electrostatic potential using the Merz-Kollman
scheme (Besler et al., 1990), as implemented in Gaussian-98 software (Frisch
et al., 1998). In the charge calculation, the wavefunction was perturbed by
protein and solvent point charges, scaled by a factor of 4. For the rest of the
protein (and side chains of the heme group), partial charges from the
CHARMM param27 force ﬁeld (MacKerell et al., 1998) were used.
Optimized radii were used for all protein atoms in the MEAD calculations
(Nina and Roux, 1997) and for the atoms that change protonation in the
various calculations (the iron oxygen ligand and the distal imidazole group), a
radii of 120, 155, and 150 PM were used for the H, N, and O atoms, respec-
tively (Ullmann et al., 2002). A unity dielectric constant (e¼ 1) was used for
the quantum system,whereas e¼ 4 in the remaining protein, and e¼ 80 in the
surroundings (water). These values have previously been shown to provide
reasonable agreement with experimental results (Ullmann et al., 2002;
Bashford et al., 1993; T. Rasmussen, K. Nilsson, and U. Ryde, unpublished).
The MEAD calculations were based on the quantum-reﬁned geometries.
All water molecules were removed. The MEAD calculations were
performed with 1513 grid points, with a coarse grid with a spacing of
100 pm, centered on the geometric center of the protein, and a dense grid with
a spacing of 20 pm, centered on the iron ion. The solvent energies are the
average of seven calculations in which the grid origin was moved 10 pm in
positive and negative directions along each Cartesian axis. The maximum
difference among the four calculations is 2 kJ/mol.
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The reported energies are the sum of the QM energies of the quantum
system and the MEAD solvation energies of the QM system in the protein
and the surrounding solvent. The intrinsic and solvation energy of the
protein was assumed to be constant for the various states. The QM energies
were calculated with the B3LYP function, as implemented in Gaussian-98
(Frisch et al., 1998; Hertwig and Koch, 1997), because this functional is
known to give more accurate energies, especially for transition metal
systems (Bauschlicher, 1995; Siegbahn and Blomberg, 2000; the same
functional was used for the charge calculations). The wavefunction was
perturbed by the protein and solvent point charges, scaled by a factor of 4,
but the energy was calculated without these charges in a single SCF iteration.
RESULTS AND DISCUSSION
Vacuum calculations
As mentioned above, compound II is normally assumed to be
FeIV O2 (which is often written as Fe¼O, but we prefer to
explicitly show the formal oxidation and protonation states),
but the FeIV OH and FeIII OH_ forms have also been
suggested (Hersleth et al., 2002). The aim of the present
investigation is to determine the actual protonation and ox-
idation state of compound II in myoglobin, observed in the
crystal structure of Hersleth et al. (2002). Therefore, we have
studied three formal oxidation states for iron, FeIII, FeIV, and
FeV, and three protonation states for water, H2O, OH
, and
O2. Based on the expected protonation states for the various
ions,we decided to study the following six combinations: FeIII
H2O, Fe
III OH, FeIII O2, FeIVOH, FeIVO2, andFeVO2.
To get a ﬁrst feeling of the optimum structures of these
complexes and also to get some insight in their most stable
spin states (some have not been observed experimentally),
we optimized the structures of the three reasonable spin
states (high-, intermediate-, and low-spin), using the
Fe(Por)(Im)(H2O/OH
/O2) model (Fig. 2). The results of
these calculations are shown in Table 1.
FeIII H2O (met-myoglobin) is experimentally known to be
in the high-spin (sextet) state (Hersleth et al., 2002). The FeIII
OH model is most stable in the low-spin (doublet) state
(Sitter et al., 1988), as can be seen in Table 1, whereas the FeIII
O2 model has nearly degenerate double and quartet states
(the former is 6 kJ/mol more stable). For the FeIV models, the
triplet (intermediate-spin) state was found to be lowest in
energy. Again, this is in accordance with experimental data
for compound II in myoglobin, as well as in peroxidases
(Foote et al., 1989). For the compound I model (FeVO2), the
doublet and quartet states are almost degenerate, but in our
calculations, the quartet is slightly lower in energy. In the
peroxidases, the doublet state is observed experimentally,
with a J-coupling constant of only 0–10 cm1 (Green, 2001)
to the radical on heme or on an amino acid. Since the axial
ligation differs betweenmyoglobin and peroxidases (the latter
has a carboxylate group hydrogen-bonded to the His ligand,
giving it some imidazolate character), and since the two states
have very similar geometries, we decided to run all FeV O2
calculations with the quartet state. In the following, we will
only discuss these spin states.
The geometries of the various complexes are also shown
in Table 1. For the most stable spin states, we get a Fe–O
distance of 240 pm for FeIII H2O, 182 pm for Fe
III OH, 166
pm for FeIII O2, 178 pm for FeIV OH, 165 pm for FeIV
O2, and 163–165 pm for FeV O2 Thus, based on these
data, neither of the models give a Fe–O distance close to that
observed in the crystal structure of compound II in myo-
globin (192 pm), but that of FeIII OH is closest to it.
Interestingly, the crystal structure shows a long Fe–NHis
bond length of 214 pm. This is appreciably longer than in the
OH models (204–206 pm), but similar to what is found for
FIGURE 2 The small Fe(Por)(Im)(OH) model of the heme active site
used in some of the vacuum calculations.
TABLE 1 Vacuum structures of the Fe(Por)(His)(O/OH/H2O)
model and relative energies of the various spin states (DE )
Ox. # Unpaired
Distance to Fe (pm)
DE
state Ligand spin NPor NHis O kJ/mol
III H2O 5 205–208 215 240
III OH 1 201–202 206 182 0.0
III 3 202–203 261 191 75.6
III 5 208–210 256 188 106.2
III O2* 1 203–204 219 166 0.0
III 3 203–204 218 165 5.8
IV OH 0y 196–205 204 179 24.2
IV 2 196–203 205 178 0.0
IV 4 196–213 218 183 101.2
IV H2O 0
y 200 194 205 3.1
IV 0 194–204 194 204 38.2
IV 2 198–199 194 205 0.0
IV 4 198 218 241 22.2
IV O2 0y 202 217 165 32.0
IV 2 202 217 165 0.0
IV 4 209 217 164 90.5
V OH 1 201–202 205 181 0.0
V 3 202–203 262 191 76.1
V 5 208–210 257 188 106.6
V O2 1 197–206 213 163 5.5
V 3 199 213 165 0.0
V 5 199 214 165 181.5
Crystal 197–205 214 192
*The His ligand dissociates in the sextet state.
yOpen-shell singlet.
3440 Nilsson et al.
Biophysical Journal 87(5) 3437–3447
the H2O and O
2 complexes (213–219 pm). Thus, these
small models give little explanation to the observed crystal
structure.
The results of these vacuum calculations are similar to
those obtained in earlier studies of similar sites (Ghosh et al.,
1994; Antony et al., 1997; Kuramochi et al., 1997; Wirstam
et al., 1999; Harris, 2001; Harris and Loew, 2001; Rovira
and Fita, 2003; Rydberg et al., 2004). In particular, a recent
study of compound II in catalase and peroxidase gave Fe–O
distances of 177 pm when protonated and 168–169 pm
when unprotonated (Rovira and Fita, 2003).
As mentioned above, the distal His forms a hydrogen bond
to the oxygen ligand in myoglobin via the Ne2 atom. It is
conceivable that such a hydrogen bond may modify the Fe–O
distance. Therefore, we added a model of the distal His to
the quantum system, yielding the Fe(Por)(Im)(H2O/OH
/
O2)(Im) model (Fig. 3). Unfortunately, the protonation
state of a His residue is not clear from crystal structures; it
can be protonated either on the Nd1 atom, the Ne2 atom, or on
both atoms. We will call these three possibilities HID, HIE,
and HIP. Clearly, if there is a water ligand, the distal His
residue must be of the HID type, to accept a hydrogen bond
(Fig. 3 a), whereas if the ligand is O2, it must be either HIE
or HIP, to donate a hydrogen bond. However, for the OH
ligand, all three protonation states are possible. This gives
us 12 different models of the active site, which were all
optimized and are described in Table 2. For the FeIV H2O–
HIE state, the proton moved from H2O to HIE, forming the
FeIV OH HIP complex. Likewise, the FeIII O2 HIP
complex reorganized to the FeIII OH HIE complex.
From this table, it can be seen that the hydrogen bond has
a quite strong inﬂuence on the Fe–O distance. Thus, if the
O-ligand is a donator (the HID structures), the Fe–O distances
decrease by 2–9 pm, whereas when it is an acceptor, the Fe–
O distance increases by 1–8 pm, more for OH than O2
and also more for HIP than HIE. Therefore, the Fe–O bonds
in the FeIV OH HIP (186 pm) and FeIII OH HIE structures
(184 pm) are only 6–8 pm shorter than in the crystal
structure.
However, the hydrogen bond to the distal His residue also
affects the (quite ﬂexible) distance to the proximal His
residue. The HIP models give the shortest bonds and the HID
models the longest with a variation of up to 8 pm. As with
the small model, it is in general the models with the shortest
Fe–O bond that give a Fe–NHis bond length most similar to
the crystal structure. Yet, the FeIV OH/HID model also
gives a quite reasonable Fe–NHis bond length (209 pm).
This indicates that there actually may be a reasonable
interpretation of the crystal structure, although the direct
comparison with vacuum structures cannot unambiguously
point out the best candidate because different models give
the best results for the Fe–O and Fe–NHis bonds. If we simply
take the sum of the absolute deviations of these two bonds,
the FeIV OH HIP (16 pm) and FeIII OH HIE (17 pm)
models give the best results. However, such a treatment does
not take into account the other bond lengths (and angles)
in the structure, nor does it take into account the relative
strength of the bonds (a Fe–O2 bond is much stiffer than a
Fe–H2O bond). All this is considered in the quantum reﬁne-
ment procedure, which can be seen as a quantum chemical
method with restraints to the crystallographic raw data. Thus,
it also disregards possible errors in the crystallographic co-
ordinates (which are not the raw data but the result of an in-
volved process of interpretation) and it considers how well
the positions of the various atoms are determined (giving a
stronger restraint to a well-determined atom than to a more
poorly determined one), thereby obtaining an optimum com-
promise between crystallography and quantum chemistry.
Finally, we also tested if the distal residues in heme
peroxidases have a similar effect. Thus, we added
CH3NHC(NH2)2 as a model of the distal arginine (Arg)
residue in these enzymes. To ensure that this model forms
a hydrogen bond to the oxo group only with the inner
nitrogen atom, we also added a water molecule, bridging the
FIGURE 3 The Fe(Por)(Im)(OH)(Im) model of the active heme site used
in both the vacuum and quantum-reﬁnement calculations. The three ﬁgures
illustrate the three possible protonation states of the distal His model—HID,
HIE, and HIP.
TABLE 2 Vacuum structures of the Fe(Por)(Im)(O/OH/H2O)(Im)
model
Distance to Fe (PM)
Ox. state Ligand His NPor NHis O O–N/H
III H2O HID 205–209 222 219 267/104
III OH HID 201–202 207 180 292/100
III HIE 201–202 206 184 282/178
III* HIP 201–202 201 188 255/148
III O2 HIE 201–203 219 170 271/165
IV* H2O HID 196–202 197 194 253/105
IV OH HID 201–202 209 171 253/111
IV HIE 198–202 205 182 284/180
IV HIP 195–203 201 186 268/161
IV Arg 201–204 200 189 269/163
IV O2 HIE 202–203 217 166 286/182
IV HIP 202–203 213 168 255/142
IV Arg 202 212 167 277/172
V O2 HIE 200–201 211 166 282/179
V HIP 200 209 167 270/164
Crystal 197–205 214 192 270/
*Fixed N–H distance.
Compound II in Myoglobin 3441
Biophysical Journal 87(5) 3437–3447
oxo group and the terminal nitrogen atom of the Arg model.
The results of these optimizations (for FeIV OH and FeIV
O2) are also shown in Table 2 (Arg entries). It can be seen
that the geometries are similar to those obtained with the His
models, especially the charged HIP model; the Fe–O bond is
167 pm for the FeIV O2 structure, but 189 pm in the FeIV
OH structure. The latter estimate is close to the distance
observed in the recent crystal structures of compound II in
HRP and compound I in cytochrome c peroxidase (184–187
PM) (Berglund et al., 2002; Bonagura et al., 2003). This
shows that myoglobin and peroxidase models behave in a
similar manner.
Quantum reﬁnement
We re-reﬁned the crystal structure of compound II in
myoglobin (Hersleth et al., 2002) using the same 12 models
of the heme site as in the vacuum calculations. All 12 models
converged to distinct structures, but two states, which we
also tried, FeIV H2O HID and Fe
III O2 HIP, converged to
FeIV OH HIP and FeIII OH HID by an internal proton
transfer. All structures were optimized for a range of values
for the wA factor, to ﬁnd the optimum choice. For all models,
either wA ¼ 1 or the default wA ¼ 0.25 gave the minimum in
Rfree factor and these results are presented in Table 3. It
should be noted that most of the entries in this table are
comparable only if the same value of wA has been used.
We will use six different criteria to evaluate which of the
structures ﬁt the crystal data best. These are the R and Rfree
factors, strain energies, the divergence of the Fe–O and Fe–
NHis distances from those observed in vacuum, and electron-
density maps. Strain energies (DEQM1 in Table 3) are
calculated as the difference in QM energy of the active site
optimized in vacuum or in the protein, and therefore mea-
sures how much the structure has to be distorted to ﬁt into
the experimental electron density.
All calculations except one give improved structures in
terms of the Rfree factor. However, the reduction (and
variation between the various structures) is very small, from
0.2056 to 0.2059. This is quite normal for the quantum
reﬁnement (Ryde and Nilsson, 2003b) and reﬂects that the
Rfree factor is a global property of the whole crystal structure,
and we make only small changes for 57 atoms (out of 1412)
in the active site. Our previous calculations (Ryde and
Nilsson, 2003b) have shown that even if the variation in the
Rfree factor is small, it is reproducible and makes sense (e.g.,
Rfree shows a nice minimum when the wA factor is varied).
Therefore, we have some conﬁdence to compare Rfree factors
obtained for the various models.
From Table 3 it can be seen that the lowest Rfree factors are
obtained for FeIII OH (especially with HID and HIE) and
FeIV OH (especially with HIP), whereas FeIII H2O, Fe
III
O2, FeIV O2, and FeV O2 give high values.
The standard R-factor shows a similar variation, but it is
always slightly higher than in the original crystal structure
(0.1802–0.1807, compared to 0.1801). This actually also
ﬂags an improvement, because both the Rfree factor and the
difference between Rfree and R should be minimized. The
R-factor is smallest for FeIII OH HID and FeIII H2O HID,
whereas the O2models give the largest values. The R-factor
is always lower for wA¼ 1 than for wA¼ 0.25, reﬂecting the
stronger restraints toward the crystallographic data in the
former calculations.
The strain energy (DEQM1) is lowest (23–35 kJ/mol) for
the FeIII OH HID/HIE and FeIV OH HIE structures. Most
of the other structures have a strain energy of 40–50 kJ/mol,
but the two FeIV/FeV O2HIP structures have an appreciably
higher strain energy (125–152 kJ/mol).
The Fe–O distances show a quite appreciable variation for
the various models, 169–206 pm. This reﬂects that this bond
is quite stiff in the quantum chemical calculations, especially
for O2 and OH. It is notable that all structures, except
those with FeIII H2O, give Fe–O bonds shorter than those in
the original crystal structure, although the difference for FeIII
OH HIP is not large. The stiffness of this bond is also
reﬂected in the small deviation between the ComQum-X and
vacuum distances for the various models. It varies between
1 and 12 pm (19 pm for FeIII H2O) and is smallest for Fe
III
OH HIE and FeIV OH HIP. As usual, the O2 structures
(but also the FeIV OH HID structure) give the worst results.
The Fe–NHis distance shows an even smaller variation,
205–212 pm, reﬂecting that it is quite ﬂexible in the
quantum chemical calculations. It is notable that it is always
shorter than in the original crystal structure, indicating that
this distance was somewhat too long. Interestingly, the
smallest deviation from the vacuum structures is obtained for
the FeV O2 and the FeIV OH HID structures, i.e., those
that gave the worst Fe–O bonds and strain energies. This
reﬂects the inconsistency between the Fe–O and Fe–NHis
bonds, observed already for the vacuum structures.
If we consider all of these results, it is clear that the normal
interpretation of compound II, FeIV O2 ﬁts the crystal data
worst. It is also clear that FeIII O2 and FeV O2 are poor
interpretations of the crystal structure. On the other hand,
FeIII OH HID and HIE seem to give the best results, both
being always among the best structures with all criteria. The
FeIV OH HIE and HIP structures also seem to give a
reasonable ﬁt to the crystallographic data.
These conclusions are conﬁrmed by an inspection of the
electron-density maps. Fig. 4 shows a comparison of the
original crystal structure and the re-reﬁned structure with
the FeIV OHHIEmodel. Only small differences between the
two structures can be seen. This ﬁgure also shows the fo–fc
difference map of the original crystal structure at the 63s
level, which has quite a few features of both positive and
negative residual density. However, if these are compared
with the difference maps of two ComQum-X structures (the
FeIII OH HIE and FeIV OH HIE models), shown in Fig. 5,
a strong improvement (less residual density) can be seen for
both structures. On the other hand, it is very hard to
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distinguish between the two ComQum-X structures because
they show similar features of almost equal volumes.
Concluding remarks
We have studied compound II in myoglobin by re-reﬁning
a 135-pm resolution crystal structure using 12 different
protonation and oxidation states of the iron ion, the O-ligand,
and the distal His residue. The results clearly show that the
crystal structure does not contain a FeIV O2 complex.
Instead, it seems to contain a FeIII OH or FeIV OH
complex. However, none of the tested models ﬁt perfectly
into the electron density. Instead, there is an inconsistency
between the observed Fe–O and Fe–NHis distances, which
are not reproduced by any of the tested vacuum structures.
This may indicate that the crystal structure is actually a mix-
ture of at least two different oxidation or protonation states.
Alternatively, the surrounding of the proximal His ligand
in myoglobin may stabilize an elongated Fe–NHis bond
length (Chance et al., 1986a).
The basis of our quantum reﬁnement method is of course
that our quantum chemical calculations give accurate results.
Previous investigations and calibrations have shown that this
is the case for metal complexes studied with the present
density-functional method and basis set (Ryde and Nilsson,
2003b). In particular, the method reproduces Fe–NPor, Fe–
NHis, and Fe–SMet bond lengths in cytochrome models
within 3, 2, and 3 pm, respectively, and reproduce Fe–ligand
bond lengths in a 95-pm crystal structure of cytochrome c553
to within 3 pm (Ryde and Nilsson, 2003a).
In the present investigation, we see that our optimized
Fe–O distance for compound I (FeV O2), 165–167 pm, is
in excellent accordance with experimental (crystallographic
and EXAFS) data, 165–172 pm, for cytochrome P450,
catalase, cytochrome c peroxidase, and HRP (Schlichting
et al., 2000; Chance et al., 1986b; Gouet et al., 1996; Green
et al., 2004). Moreover, our results reproduce the expectation
that deprotonated compound II (FeIV O2) should have a
similar Fe–O distance (165–168 pm; it is 164–171 pm in a
crystal structure of catalase and EXAFS structures of myo-
globin and HRP; Chance et al., 1986a; Penner-Hahn et al.,
1986; Gouet et al., 1996). Therefore, we have some conﬁ-
dence that our calculated structures can be trusted to within
3–5 pm.
Some of the systems studied have the same atoms and the
same number of electrons. Therefore, their energies are
comparable. It can be of some interest to compare these
energies to get a feeling of the intrinsic stabilities and how
they are changed in the protein. First, the HIE form of FeIII
(i.e., where OH is the acceptor of a hydrogen bond from the
distal His) is 28 kJ/mol more stable than the HID form in
vacuum. In the protein this has increased to 95 kJ/mol (for
TABLE 3 ComQum-X results for the active site in myoglobin compound II (Hersleth et al., 2002)
Distance to Fe (PM)
Ox. state Ligand His wA DEQM1 kJ/mol NPor NHis O O–N/H Rfree R
III H2O HID 0.25 41.9 202–209 212 206 259/107 0.20594 0.18058
III 1.0 56.2 199–206 210 200 262/107 0.20572 0.18020
III OH HID 0.25 22.8 199–204 209 182 277/100 0.20560 0.18041
III 1.0 34.9 197–203 208 185 272/100 0.20561 0.18020
III HIE 0.25 33.4 198–204 207 185 273/171 0.20565 0.18048
III 1.0 34.6 196–203 208 188 271/168 0.20568 0.18020
III HIP 0.25 41.9 199–203 205 191 259/143 0.20594 0.18047
III 1.0 44.8 197–203 207 192 264/150 0.20577 0.18018
III O2 HIE 0.25 34.1 199–204 211 174 273/167 0.20587 0.18068
III 1.0 44.0 197–203 209 182 271/163 0.20579 0.18027
IV OH HID 0.25 40.9 198–204 209 177 271/105 0.20573 0.18055
IV 1.0 47.9 197–203 209 183 271/104 0.20569 0.18024
IV HIE 0.25 32.8 197–204 207 184 273/170 0.20567 0.18050
IV 1.0 34.4 196–203 208 187 270/168 0.20570 0.18027
IV HIP 0.25 44.9 196–205 206 186 270/164 0.20564 0.18047
IV 1.0 45.9 195–204 207 189 270/163 0.20565 0.18020
IV O2 HIE 0.25 33.3 200–205 211 169 280/177 0.20587 0.18075
IV 1.0 46.2 197–204 210 176 276/173 0.20579 0.18037
IV HIP 0.25 129.3 200–204 211 171 270/160 0.20572 0.18068
IV 1.0 152.2 197–204 210 179 271/161 0.20567 0.18032
V O2 HIE 0.25 41.4 200–204 210 169 277/174 0.20590 0.18075
V 1.0 51.5 197–204 209 176 274/170 0.20583 0.18037
V HIP 0.25 125.1 200–204 210 170 275/167 0.20570 0.18062
V 1.0 146.5 197–203 209 178 274/167 0.20570 0.18033
Crystal 197–205 214 192 270/ 0.20593 0.18010
Fe–ligand distances, strain energies (DEQM1), and R-factors are tabulated for the various oxidation and protonation states.
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the structures obtained with wA ¼ 0.25). For FeIV, the HID
form is most stable both in vacuum (by 46 kJ/mol) and in the
protein (by 5 kJ/mol). Finally, we can also compare FeIII
H2O HID with Fe
III OHHIP. It turns out that the latter form
is most stable, both in vacuum and in the protein (by 83 and
23 kJ/mol, respectively).
In the original article of the crystal structure (Hersleth
et al., 2002), it was suggested that the compound II structure
represents a FeIII OH_ state or possibly FeIV OH. This con-
clusion was based on the long Fe–O distance and the short
hydrogen bond to the distal His residue (N–O distance of
270 pm). In our vacuum calculations, the N–O hydrogen-
bond length varies quite appreciably, e.g., from 252 to 293
pm in vacuum. All distances for HIE are ;285 pm, whereas
those of HID and HIP vary much more. The length of the
H-acceptor interaction is 142–182 pm, indicating a quite
strong interaction. In the ComQum-X structures, the variation
is smaller, 259–280 pm—i.e., quite well centered around the
value in the original structure. Thus, our results give no
evidence that the oxidation and protonation state of the active
site can be determined from the hydrogen-bond length.
The suggestion that the species observed is FeIII OH_ also
needs some comments. This state involves the same nuclei
and the same number of electrons as the FeIV OH state. The
only difference is the transfer of an electron from FeIII to
OH_. Thus, they are two electronic states of the same
complex. In our calculations, one of them should therefore
come out as the ground state, whereas the other is an excited
state. To show the electronic structure of the various states,
we have calculated the spin density of the different groups in
the various complexes in Table 4. It can be seen that the FeIV
OH complexes show a spin population of 1.39–1.55 on
iron. This is intermediate between what is expected for FeIII
and FeIV. The spin population on OH varies with the distal
His model. In the HIE and HIP complexes, there is 0.13–0.17
e on OH, indicating almost a pure OH ion. The rest of the
spin is located either in the porphyrin ring or on the distal His
model. However, in the HID complex there are 0.46 unpaired
electrons on the oxygen ligands, indicating that its electronic
structure is almost between OH and OH_. These trends
remain also in the ComQum-X structures, even if the length
of the hydrogen bond is almost identical in these. We have
made many attempts to ﬁnd a pure wavefunction that
corresponds to the FeIII OH_ description, but without any
success. Thus, it is hard to discern between the FeIII OH_and
FeIV OH descriptions and it may actually be that the
electron density is so delocalized that the truth is in between
these two descriptions (as was seen for the HID complex).
Moreover, it can be expected that the character varies
signiﬁcantly with small changes in the surroundings. A con-
clusive description of the actual electronic structure of the
FIGURE 4 A comparison of the original crystal structure (magenta) and
the re-reﬁned structure of FeIV OHHIE. Also included is the fo–fc difference
map of the original crystal structure at the 63.0s level (cyan and yellow).
FIGURE 5 A comparison of the ComQum-X structures of the FeIII
OH HIE (magenta) and FeIV OH HIE models. Also included are the fo–fc
difference maps of the two structures at the 63.0s level (blue and white for
FeIII and green and red for FeIV).
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states can only be obtained with more advanced, multi-
conﬁgurational methods.
The fact that the crystal should contain compound II and
not compound I or FeIII is based on an investigation of the
electron paramagnetic resonance spectrum, which shows that
the FeIII signal disappears when treating the crystals with
H2O2 (Hersleth et al., 2002). It is replaced by a compound
I signal, but it amounts to ,2% of the original signal, in-
dicating that the majority of the sites are in a different state
with an even number of electrons. The conclusion that it is
compound II is also supported by the change in color of the
crystal (Hersleth et al., 2002). It has been checked by
microspectrophotometry that the oxidation state of myoglo-
bin compound II crystals does not change signiﬁcantly
during data collection at SNBL/BM1 at the European
Synchrotron Radiation Facility in Grenoble, France.
The experimental evidence for compound II in heme
proteins is somewhat messy. As mentioned before, a crystal
structure of compound II in catalase (Gouet et al., 1996)
gives a short Fe–O bond of 171 pm, indicating the FeIV O2
state. However, the present crystal structure, two recent
structures of compound II in HRP and catalase, as well as the
crystal structure of compound I in cytochrome c peroxidase
(with the extra oxidizing equivalent on a tryptophane
radical), indicate a longer bond, 184–192 pm (Berglund
et al., 2002; Hersleth et al., 2002; Murshudov et al., 2002;
Bonagura et al., 2003). These long bonds were interpreted as
a single Fe–O bond caused by the protonation of the oxygen
atom. Likewise, there are three EXAFS studies that indicate
a short Fe–O bond of compound II in myoglobin and HRP
(164–170 pm; Chance et al., 1986a; Penner-Hahn et al.,
1986; Green et al., 2004), but there is also another study on
HRP that gave a long Fe–O bond (193 pm; Chance et al.,
1984). The two spectra from HRP are clearly different,
showing that the difference is not caused by errors in the
ﬁtting procedure (Penner-Hahn et al., 1986). Thus, at least
two forms of compound II seem to exist. A long EXAFS
Fe–O bond (182 pm) was also found for compound II in
chloroperoxidase (with an axial cysteine Fe ligand), but the
same authors obtained a short bond for HRP (170 pm) and
they question the long bonds observed in the other enzymes
(Green et al., 2004). Thus, the nature of compound II in heme
proteins is still controversial.
The situation is even more complicated by the observation
of two pH-dependent states of compound II in peroxidases by
resonance Raman and variable-temperature magnetic circular
dichroism (Paeng and Kincaid, 1988; Sitter et al., 1985;
Andersson and Dawson, 1991; Foote et al., 1989). For HRP,
the transition between the two states is around pH 8.5 and the
alkaline form has a higher frequency of the Fe–O bond (788
compared to 776 cm1; Sitter et al., 1988). Both pH states are
suggested to be FeIV O2, but at high pH, there should be no
hydrogen bond to the distal His residue (the Fe–O frequency
is insensitive to deuterium exchange; Sitter et al., 1988). For
myoglobin, a similar transition is observed around pH 3.5 and
the form at normal pH is most similar to the alkaline form of
HRP compound II (Sitter et al., 1985; Foote et al., 1989). The
low-pH form is highly unstable and has been interpreted as
having a protonated distal His residue that swings out into the
solvent, making the heme site more exposed (Foote et al.,
1989). Thus, these two pH forms cannot explain the
differences in the Fe–O distance, observed by EXAFS and
crystallography (concerning the protonation of the iron-
bound water molecule).
This is in accordance with the resonance Raman spectrum
of our myoglobin crystals and solution (T. Uchida, H.-P.
Hersleth, T. Kitagawa, K. K. Andersson, unpublished data):
It shows an appreciably lower Fe–O frequency (below 700
cm1), in agreement with the long Fe–O bond.
If we take all this experimental data together with our
results and trust that the crystal is not reduced during data
collection, the most probable interpretation of compound II
in our crystals of myoglobin seems to be the FeIV OH state
in the HIE or HIP forms, in which the distal His donates
a hydrogen bond to the iron-bound OH group (these two
states also ﬁt the crystal structure best). It is possible that the
distal His group protonates in the physiological pH range,
which could explain the variation observed in the O–N
distance between the O-ligand and the distal His group in
crystal structures collected at pH 5.2 (270 pm), 6.8 (288
pm), and 8.7 (294 pm; H.-P. Hersleth, C. H. Go¨rbitz, K. K.
Andersson, unpublished data; Hersleth et al., 2001). These
structures show no signiﬁcant changes in the other structural
parameters. This interpretation is in accordance with a 16-pm
increase in the O–N distance for the FeIV OH HIE/HIP
models in Table 2.




Ox. state Ligand His Fe O-ligand Por Improx Imdist
III H2O 4.13 0.03 0.72 0.11
III HID 4.16 0.07 0.66 0.10 0.01
III OH 0.87 0.21 0.07 0.00
III HID 0.84 0.24 0.08 0.01 0.00
III HIE 0.92 0.14 0.06 0.01 0.00
III HIP 0.97 0.08 0.05 0.00 0.00
III O2 1.12 0.79 0.90 0.01
III HIE 1.05 0.63 0.67 0.02 0.00
IV H2O 1.07 0.01 0.92 0.01
IV HID 1.21 0.03 0.75 0.00 0.00
IV OH 1.53 0.26 0.21 0.00
IV HID 1.55 0.45 0.02 0.01 0.03
IV HIE 1.43 0.17 0.12 0.01 0.29
IV HIP 1.39 0.13 0.48 0.00 0.00
IV O2 1.17 0.89 0.05 0.01
IV HIE 1.25 0.81 0.05 0.01 0.00
IV HIP 1.37 0.65 0.06 0.02 0.02
V OH 0.87 0.21 0.07 0.01
V O2 1.43 0.94 0.63 0.00
V HIE 1.38 0.84 0.44 0.00 0.33
V HIP 1.16 0.82 0.99 0.05 0.01
Compound II in Myoglobin 3445
Biophysical Journal 87(5) 3437–3447
We are grateful for help from the team at the Swiss-Norwegian Beam Line/
BM1 at the European Synchrotron Radiation Facility, Grenoble, France.
This investigation has been supported by grants from the Crafoord
Foundation and the Swedish Research Council. It has also been supported
by computer resources of Lunarc at Lund University.
REFERENCES
Adams, P. D., N. S. Pannu, R. J. Read, and A. T. Brunger. 1997. Cross-
validated maximum likelihood enhances crystallographic simulated
annealing reﬁnement. Proc. Natl. Acad. Sci. USA. 94:5018–5023.
Ahlrichs, R., M. Ba¨r, H.-P. Baron, R. Bauernschmitt, S. Bo¨cker, M. Ehrig,
K. Eichkorn, S. Elliott, F. Haase, M. Ha¨ser, H. Horn, C. Huber, C.
Ko¨lmel, M. Kollwitz, C. Ochsenfeld, H. O¨hm, A. Scha¨fer, U. Schneider,
O. Treutler, M. von Arnim, F. Weigend, P. Weis, and H. Weiss. 2000.
TURBOMOLE. Universita¨t Karlsruhe, Germany.
Andersson, L. A., and J. H. Dawson. 1991. EXAFS spectroscopy of heme-
containing oxygenases and peroxidases. Struct. Bond. 74:1–40.
Antony, J., M. Grodzicki, and A. X. Trautwein. 1997. Local density
functional study of oxoironIV porphyrin complexes and their one-electron
oxidized derivatives. Axial ligand effects. J. Phys. Chem. A. 101:2692–
2701.
Bashford, D. 1997. An object-oriented programming suite for electrostatic
effects in biological molecules. In Scientiﬁc Computing in Object-
Oriented Parallel Environments, Lecture Notes in Computer Science,
Vol. 134. Y. Ishikawa, R.R. Oldehoeft, J.V.W. Reynders, and
M. Tholburn, editors. Springer, Berlin, Germany. 233–240.
Bashford, D., D. A. Case, C. Dalvit, L. Tennant, and P. E. Wright. 1993.
Electrostatic calculations of side-chain pKa values in myoglobin and
comparison with NMR data for histidines. Biochemistry. 32:8045–8056.
Bauschlicher, C. W. 1995. A comparison of the accuracy of different
functionals. Chem. Phys. Lett. 246:40–44.
Becke, A. 1988. Density-functional exchange-energy approximation with
correct asymptotic behavior. Phys. Rev. A. 38:3098–3100.
Benini, S., A. Gonza´lez, W. R. Rypniewski, K. S. Wilson, J. J. Van
Beeumen, and S. Ciurli. 2000. Crystal structure of oxidized Bacillus
pasteurii cytochrome c553 at 0.97-A˚ resolution. Biochemistry. 39:13115–
13126.
Berglund, G. I., G. H. Carlsson, A. T. Smith, H. Szo¨rke, A. Henriksen, and
J. Hajdu. 2002. The catalytic pathway of horseradish peroxidase at high
resolution. Nature. 417:463–468.
Besler, B. H., K. M. Merz, and P. A. Kollman. 1990. Atomic charges
derived from semiempirical methods. J. Comput. Chem. 11:431–439.
Bonagura, C. A., B. Bhaskar, H. Shimizu, H. Li, M. Sundaramoorthy,
D. E. McRee, D. B. Goodin, and T. L. Poulos. 2003. High-resolution
crystal structures and spectroscopy of native and compound I cytochrome
c peroxidase. Biochemistry. 42:5600–5608.
Bru¨nger, A. T. 1993. Assessment of phase accuracy by cross validation: the
free R-value. Methods and applications. Acta Crystallogr. D49:24–36.
Bru¨nger, A. T., and L. M. Rice. 1997. Crystallographic reﬁnement by
simulated annealing. Methods and applications. Meth. Enzymol. 277:
243–269.
Bru¨nger, A. T., P. D. Adams, G. M. Clore, W. L. Delano, P. Gros, R. W.
Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Niges, N. S. Pannu, R. J.
Read, L. M. Rice, T. Simonson, and G. L. Warren. 2000. Crystallog-
raphy and NMR System CNS, Ver. 1.0. Yale University, New Haven,
CT.
Chance, M., L. Powers, Y. Chiang, T. Poulos, G. R. Schonbaum,
I. Yamazaki, and K. G. Paul. 1984. X-ray absorption studies of in-
termediates in peroxidase activity. Arch. Biochem. Biophys. 235:596–
611.
Chance, M., L. Powers, C. Kumar, and B. Chance. 1986a. X-ray absorption
studies of myoglobin peroxide reveal functional differences between
globins and heme enzymes. Biochemistry. 25:1259–1265.
Chance, M., L. Powers, T. Poulos, and B. Chance. 1986b. Cytochrome c
peroxidase compound ES is identical with horseradish peroxidase
compound I in iron-ligand distances. Biochemistry. 25:1266–1270.
da Silvia, J. J. R. F., and P. J. Williams. 1994. The Biological Chemistry of
the Elements. Clarendon Press, Oxford, UK.
Egawa, T., H. Shimada, and Y. Ishimura. 2000. Formation of compound I
in the reaction of native myoglobin with hydrogen peroxide. J. Biol.
Chem. 275:34858–34866.
Eichkorn, K., O. Treutler, H. O¨hm, M. Ha¨ser, and R. Ahlrichs. 1995.
Auxiliary basis sets to approximate Coulomb potentials. Chem. Phys.
Lett. 240:283–290.
Eichkorn, K., F. Weigend, O. Treutler, and R. Ahlrichs. 1997. Auxiliary
basis sets for main row and transition metals and their use to approximate
Coulomb potentials. Theor. Chim. Acta. 97:119–124.
Engh, R. A., and R. Huber. 1991. Accurate bond and angle parameters for
x-ray protein structure reﬁnement. Acta Crystallogr. A47:392–400.
Foote, N., P. M. A. Gadsby, C. Greenwood, and A. J. Thompson. 1989.
pH-dependent forms of the ferryl heme in myoglobin peroxide analysed
by variable-temperature magnetic circular dichroism. J. Biol. Chem.
261:515–522.
Frisch, M. J., G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb,
J. R. Cheeseman, V. G. Zakrzewski, J. A. Montgomery, R. E. Stratmann,
J. C. Burant, S. Dapprich, J. M. Millam, A. D. Daniels, K. N. Kudin,
M. C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi,
B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski,
G. A. Petersson, P. Y. Ayala, Q. Cui, K. Morokuma, D. K. Malick,
A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. Cioslowski,
J. V. Ortiz, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz,
I. Komaromi, R. Gomperts, R. L. Martin, D. J. Fox, T. Keith, M. A.
Al-Laham, C. Y. Peng, A. Nanayakkara, C. Gonzalez, M. Challacombe,
P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, J. L. Andres,
M. Head-Gordon, E. S. Replogle, and J. A. Pople. 1998. GAUSSIAN 98,
Rev. A.5. Gaussian Inc., Pittsburgh, PA.
Gajhede, M. 2001. Horseradish peroxidase. In Handbook of Metal-
loproteins, Vol. 1. A. Messerschmidt, R. Huber, T. Poulos, and
K. Wieghardt, editors. J. Wiley & Sons, Chichester, UK. 195–209.
Ghosh, A., J. Almlo¨f, and L. Que. 1994. Density functional theoretical
study of oxo(porphyrinato)ironIV complexes, models of peroxidase
compound I and II. J. Phys. Chem. 98:5576–5579.
Giulivi, C., and E. Cadenas. 1994. Ferrylmyoglobin: formation and
chemical reactivity toward electron-donating compounds. Methods
Enzymol. 233:189–202.
Gouet, P., H.-M. Jouve, P. A. Williams, I. Andersson, P. Adreoletti,
L. Nussaume, and J. Hajdu. 1996. Ferryl intermediates of catalase
captured by time-resolved Weissenberg crystallography and UV-VIS
spectroscopy. Nat. Struct. Biol. 3:951–956.
Green, M. T. 2001. The structure and spin coupling of catalase compound I:
a study of noncovalent effects. J. Am. Chem. Soc. 123:9218–9219.
Green, M. T., J. H. Dawson, and H. B. Gray. 2004. Oxoiron(IV) in
chloroperoxidase compound II is basic: implications for P450 chemistry.
Science. 304:1653–1656.
Hargrove, M. S., A. J. Wilkinson, and J. S. Olson. 1996. Structural factors
governing hemin dissociation from met-myoglobin. Biochemistry. 35:
11300–11309.
Harris, D. L. 2001. High-valent intermediates of heme proteins and model
compounds. Curr. Opin. Chem. Biol. 5:724–735.
Harris, D. L., and G. H. Loew. 2001. Proximal ligand effects on electronic
structure and spectra of compound I of peroxidases. J. Porph.
Phtalocyanins. 5:334–344.
Hehre, W. J., L. Radom, P. v. R. Schleyer, and J. A. Pople. 1986. Ab Initio
Molecular Orbital Theory. Wiley-Interscience, New York.
Hersleth, H. P., B. Dalhus, C. H. Go¨bitz, and K. K. Andersson. 2002. An
iron hydroxide moiety in the 1.35 A˚ resolution structure of hydrogen
peroxide derived myoglobin compound II at pH 5.2. J. Biol. Inorg.
Chem. 7:299–304.
3446 Nilsson et al.
Biophysical Journal 87(5) 3437–3447
Hersleth, H. P., B. Dalhus, C. H. Go¨rbitz, and K. K. Andersson. 2001.
Compound II in peroxidases: new resonance forms suggested by pH-
dependent structures of myoglobin intermediates formed by oxidation
with peroxides. J. Inorg. Biochem. 86:260. (Abstr.)
Hertwig, R. H., and W. Koch. 1997. On the parameterization of the local
correlation functional. What is Becke-3-Lyp? Chem. Phys. Lett. 268:
345–351.
Kaim, W., and B. Schwederski. 1994. Bioinorganic Chemistry: Inorganic
Elements in the Chemistry of Life. John Wiley & Sons, Chichester, UK.
Keilin, D., and E. F. Hartree. 1950. Effect of drying upon the absorption
spectra of hemoglobin and its derivatives. Nature. 166:513–518.
Kendrew, J. C., R. E. Dickerson, B. E. Strandberg, R. G. Hart, D. R.
Davies, D. C. Phillips, and V. C. Shore. 1960. Structure of
myoglobin—three-dimensional Fourier synthesis at 2-A˚ resolution.
Nature. 185:422–427.
Kleywegt, G. J., and T. A. Jones. 1998. Databases in protein
crystallography. Acta Crystallogr. D54:1119–1131.
Kuramochi, H., L. Noodleman, and D. A. Case. 1997. Density functional
study on the electronic structures of model peroxidase compounds I and
II. J. Am. Chem. Soc. 119:11442–11451.
MacKerell, A. D., D. M. Bashford, R. L. D. Bellott, Jr., J. D. Evanseck,
M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy,
L. Kuchnir, K. Kuczera, F. Lau, C. Mattos, S. Michnick, T. Ngo,
D. T. Nguyen, B. Prodhom, W. E. Reiher, B. Roux, M. Schlenkrich,
J. C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiorkiewicz-Kuczera,
D. Yin, and M. Karplus. 1998. All-atom empirical potential for
molecular modeling and dynamics. Studies of proteins. J. Phys. Chem.
B. 102:3586–3616.
Matsui, T., S. Ozaki, E. Liong, G. N. Phillips, and Y. Watanabe. 1999.
Effect of the location of distal histidine in the reaction of myoglobin with
hydrogen peroxide. J. Biol. Chem. 274:2838–2844.
Matsunaga, I., and Y. Shir. 2004. Peroxide-utilizing biocatalysts: structural
and functional diversity of heme-containing enzymes. Curr. Opin. Chem.
Biol. 8:127–132.
Monard, G., and K. M. Merz. 1999. Combined quantum mechanical/
molecular mechanical methodologies applied to biomolecular systems.
Acc. Chem. Res. 32:904–911.
Mulholland, A. J. 2001. The QM/MM approach to enzymatic reactions.
In Theoretical Biochemistry—Processes and Properties of Biological
Systems, Theoretical and Computational Chemistry, Vol. 9. L.A.
Eriksson, editor. Elsevier Science, Amsterdam, The Netherlands.
Murshudov, G. N., A. I. Grebenko, J. A. Brannigan, A. A. Antson,
V. V. Barynin, G. G. Dodson, Z. Dauter, K. S. Wilson, and W. R. Melik-
Adamyan. 2002. The structures of Micrococcus lysodeikticus catalase, its
ferryl intermediate (compound II) and NADPH complex. Acta
Crystallogr. D58:1972–1982.
Nicoll, R. M., S. A. Hindle, G. MacKenzie, I. H. Hillier, and N. A. Burton.
2001. Quantum mechanical/molecular mechanical methods and the study
of kinetic isotope effects: modelling the covalent junction region and
application to the enzyme xylose isomerase. Theor. Chim. Acta. 106:
105–112.
Nilsson, K., and U. Ryde. 2004. Protonation status of protein ligands can be
determined by quantum reﬁnement. J. Inorg. Biochem. 98:1539–1546.
Nina, M., and B. Roux. 1997. Atomic radii for continuum electrostatics
calculations based on molecular dynamics free energy simulations.
J. Phys. Chem. B. 101:5239–5248.
Ozaki, S., T. Matsui, and Y. Watanabe. 1997. Conversion of myoglobin into
a peroxygenase: a catalytic intermediate of sulfoxidation and epoxidation
by the F43H/H64L mutant. J. Am. Chem. Soc. 119:6666–6667.
Paeng, K. J., and J. R. Kincaid. 1988. The resonance Raman spectrum of
horseradish peroxidase compound I. J. Am. Chem. Soc. 110:7913–7915.
Pannu, N. S., and R. J. Read. 1996. Improved structure reﬁnement through
maximum likelihood. Acta Crystallogr. A52:659–668.
Penner-Hahn, J. E., K. S. Eble, T. J. McMurry, M. Renner, A. L. Balch,
J. T. Groves, and K. O. Hodgsen. 1986. Structural characterization of
horseradish peroxidase using EXAFS spectroscopy. Evidence for Fe¼O
ligation in compound I and II. J. Am. Chem. Soc. 108:7819–7825.
Perdew, J. P. 1986. Density-functional approximation for the correlation
energy of the inhomogeneous electron gas. Phys. Rev. B. 33:8822–8824.
Philips, G. N. 2001. Myoglobin. In Handbook of Metalloproteins, Vol. 1.
A. Messerschmidt, R. Huber, T. Poulos, and K. Wieghardt, editors.
Wiley & Sons, Chichester, UK. 5–15.
Poulos, T. L. 1996. The role of the proximal ligand in heme enzymes.
J. Biol. Inorg. Chem. 1:356–359.
Rovira, C., and I. Fita. 2003. The proximal hydrogen-bonded residue
controls the stability of the compound II intermediate of peroxidases and
catalases. J. Phys. Chem. B. 107:5300–5305.
Rydberg, P., E. Sigfridsson, andU.Ryde. 2004.On the role of the axial ligand
in heme proteins—a theoretical study. J. Biol. Inorg. Chem. 9:203–223.
Ryde, U. 2003. Combined quantum and molecular mechanics calculations
on metalloproteins. Curr. Opin. Chem. Biol. 7:136–142.
Ryde, U., and K. Nilsson. 2003a. Quantum chemistry can improve protein
crystal structures locally. J. Am. Chem. Soc. 125:14232–14233.
Ryde, U., and K. Nilsson. 2003b. Quantum reﬁnement—a combination of
quantum chemistry and protein crystallography. J. Mol. Struct. 632:259–
275.
Ryde, U., L. Olsen, and K. Nilsson. 2002. Quantum chemical geometry
optimisations in proteins using crystallographic raw data. J. Comput.
Chem. 23:1058–1070.
Scha¨fer, A., H. Horn, and R. Ahlrichs. 1992. Fully optimized contracted
Gaussian basis set for atoms Li to Kr. J. Chem. Phys. 97:2571–2577.
Schlichting, I., J. Berendzen, K. Chu, A. M. Stock, S. A. Maves, D. E.
Benson, R. M. Sweet, D. Ringe, G. A. Petsko, and S. G. Sligar. 2000.
The catalytic pathway of cytochrome P450cam at atomic resolution.
Science. 287:1615–1622.
Siegbahn, P. E. M., and M. R. A. Blomberg. 2000. Transition-metal
systems in biochemistry studied by high-accuracy quantum chemical
methods. Chem. Rev. 100:421–437.
Sigfridsson, E., M. H. M. Olsson, and U. Ryde. 2001. A comparison of the
inner-sphere reorganisation energies of cytochromes, iron-sulphur
clusters, and blue copper proteins. J. Phys. Chem. B. 105:5546–5552.
Sigfridsson, E., and U. Ryde. 2003. The importance of porphyrin distortions
for the ferrochelatase reaction. J. Biol. Inorg. Chem. 8:273–282.
Sitter, A. J., C. M. Reczek, and J. Terner. 1985. Heme-linked ionization of
horseradish peroxidase compound II monitored by the resonance Raman
Fe(IV)¼O stretching vibration. J. Biol. Chem. 260:7515–7522.
Sitter, A. J., J. R. Shifﬂett, and J. Terner. 1988. Resonance Raman
spectroscopic evidence for heme iron-hydroxide ligation in peroxidase
alkaline forms. J. Biol. Chem. 263:13032–13038.
Smith, A. T., and N. C. Veitch. 1998. Substrate binding and catalysis in
heme peroxidases. Curr. Opin. Chem. Biol. 2:269–278.
Spiro, T. G., and P. M. Kozlowski. 2001. Is the CO adduct of myoglobin
bent, and does it matter? Acc. Chem. Res. 34:137–144.
Tajima, G., and K. Shikama. 1987. Autoxidation of oxymyoglobin. an
overall stoichiometry including subsequent side reactions. J. Biol. Chem.
262:12603–12606.
Tishmack, P. A., D. Bashford, E. Harms, and R. I. Van Etten. 1997. Use of
1H NMR spectroscopy and computer simulations to analyze histidine pKa
changes in a protein tyrosine phosphatase: experimental and theoretical
determination of electrostatic properties in a small protein. Biochemistry.
36:11984–11994.
Ullmann, G. M., L. Noodleman, and D. A. Case. 2002. Density functional
calculation of pKa values and redox potentials in the bovine Rieske iron-
sulfur protein. J. Biol. Inorg. Chem. 7:632–639.
Wirstam, M., M. R. A. Blomberg, and P. E. M. Siegbahn. 1999. Reaction
mechanism of compound I formation in heme peroxidases: a density
functional theory study. J. Am. Chem. Soc. 121:10178–10185.
Compound II in Myoglobin 3447
Biophysical Journal 87(5) 3437–3447
